[Summary in Progress]
(422) Harrison et al. Incentives in Rheumatology: the Potential Contribution of Physician Responses to Financial Incentives, Public Reporting, and Treatment Guidelines to Health Care Sustainability. Curr Rheumatol Rep. 2016 Jul;18(7):42. doi: 10.1007/s11926-016-0596-6.
- Narrative review of which P4P incentives exist and how they influence rheumatology
- Analysis of current indicators for osteoporosis and rheumatoid arthritis in both the Affordable Care Act and the UK Quality and Outcomes Framework
- There is limited evidence for the success of incentives to improve quality of rheumatology care, and all currently focus on process measures
- Authors indicate “reporting variation in the quality and level of provision of rheumatology services appears to be a good way to identify opportunities for cost control”
Significance to Literature:
Review of current evidence and case studies for incentives which could impact “the future of incentive schemes in rheumatology”